NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB (NACOPRAD)
Primary Purpose
Cervical Cancer
Status
Not yet recruiting
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
hysterectomy
Radiation
Cisplatin
Paclitaxel
Carboplatin
Ifosfamide
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Cancer focused on measuring neoadjuvant chemotherapy, FIGO IB2, FIGO IIB, chemo-radiation, dose dense chemotherapy, cisplatin, paclitaxel, carboplatin, ifosfamide
Eligibility Criteria
Inclusion Criteria:
- >18 years
- cervical cancer FIGO IB2, IIB,
- squamous cell, adeno or adenosquamous cell carcinoma
- informed consent
Exclusion Criteria:
- small cell/neuroendocrine component
- previous radiation, previous cancer
- pregnancy
- HIV
- severe co-morbidities
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Arm A: NACT+radical hysterectomy
Arm B: Chemoradiation
Arm Description
Arm A includes patients for dose dense chemotherapy using TP (paclitaxel, carboplatin) or TIP (cisplatin, paclitaxel, ifosfamide) weekly for six cycles. Radical hysterectomy is performed after the 6th week + lymphadenectomy
Arm B includes patients undergoing primary cisplatin based chemo-radiation
Outcomes
Primary Outcome Measures
disease free survival
DFS
Secondary Outcome Measures
overall survival
local control
local control rate at 5 years
quality of life
Qol questionnaire EORTC Qol C30 and Cervical Cancer Module EORTC QLQ-CX24
Full Information
NCT ID
NCT02422563
First Posted
February 11, 2015
Last Updated
April 20, 2015
Sponsor
Charite University, Berlin, Germany
1. Study Identification
Unique Protocol Identification Number
NCT02422563
Brief Title
NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB
Acronym
NACOPRAD
Official Title
Multicenter Prospective Randomized Study on NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Patients With Cervical Cancer FIGO Stage IB2 and IIB
Study Type
Interventional
2. Study Status
Record Verification Date
April 2015
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2015 (undefined)
Primary Completion Date
October 2020 (Anticipated)
Study Completion Date
October 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charite University, Berlin, Germany
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Randomized comparison of neoadjuvant chemotherapy followed by radical hysterectomy with pelvic ± para-aortic lymphonodectomy (LNE) versus primary cisplatin-based chemo-radiation in patients with cervical cancer FIGO IB2 and IIB.
Detailed Description
The optimal treatment for patients with cervical cancer on FIGO stage IB2 and IIB is controversial. There is no randomized comparison of a dose-dense NACT (TP or TIP-schedule) followed by hysterectomy and LNE (investigational Arm A) versus primary chemo-radiation (standard arm B). Primary endpoint is the DFS at 5 years, secondary endpoints local control at 5 years, OS at 5 years, QOL, questionnaires on sexual activity/QOL.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Cancer
Keywords
neoadjuvant chemotherapy, FIGO IB2, FIGO IIB, chemo-radiation, dose dense chemotherapy, cisplatin, paclitaxel, carboplatin, ifosfamide
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
534 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Arm A: NACT+radical hysterectomy
Arm Type
Experimental
Arm Description
Arm A includes patients for dose dense chemotherapy using TP (paclitaxel, carboplatin) or TIP (cisplatin, paclitaxel, ifosfamide) weekly for six cycles. Radical hysterectomy is performed after the 6th week + lymphadenectomy
Arm Title
Arm B: Chemoradiation
Arm Type
Other
Arm Description
Arm B includes patients undergoing primary cisplatin based chemo-radiation
Intervention Type
Procedure
Intervention Name(s)
hysterectomy
Intervention Description
radical hysterectomy
Intervention Type
Radiation
Intervention Name(s)
Radiation
Intervention Type
Drug
Intervention Name(s)
Cisplatin
Intervention Type
Drug
Intervention Name(s)
Paclitaxel
Intervention Type
Drug
Intervention Name(s)
Carboplatin
Intervention Type
Drug
Intervention Name(s)
Ifosfamide
Primary Outcome Measure Information:
Title
disease free survival
Description
DFS
Time Frame
5 years
Secondary Outcome Measure Information:
Title
overall survival
Time Frame
5 years
Title
local control
Description
local control rate at 5 years
Time Frame
5 years
Title
quality of life
Description
Qol questionnaire EORTC Qol C30 and Cervical Cancer Module EORTC QLQ-CX24
Time Frame
5 years
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
>18 years
cervical cancer FIGO IB2, IIB,
squamous cell, adeno or adenosquamous cell carcinoma
informed consent
Exclusion Criteria:
small cell/neuroendocrine component
previous radiation, previous cancer
pregnancy
HIV
severe co-morbidities
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Simone Marnitz, MD
Email
simone.marnitz@charite.de
12. IPD Sharing Statement
Citations:
PubMed Identifier
2428700
Citation
Sardi JE, di Paola GR, Cachau A, Ortiz OC, Sananes C, Giaroli A, Martins D, Peluffo M. A possible new trend in the management of the carcinoma of the cervix uteri. Gynecol Oncol. 1986 Oct;25(2):139-49. doi: 10.1016/0090-8258(86)90095-8.
Results Reference
background
PubMed Identifier
11773168
Citation
Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C, Landoni F. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002 Jan 1;20(1):179-88. doi: 10.1200/JCO.2002.20.1.179.
Results Reference
background
PubMed Identifier
1699851
Citation
Sardi J, Sananes C, Giaroli A, Maya G, di Paola G. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol. 1990 Sep;38(3):486-93. doi: 10.1016/0090-8258(90)90096-4.
Results Reference
background
PubMed Identifier
1709686
Citation
Souhami L, Gil RA, Allan SE, Canary PC, Araujo CM, Pinto LH, Silveira TR. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol. 1991 Jun;9(6):970-7. doi: 10.1200/JCO.1991.9.6.970.
Results Reference
background
PubMed Identifier
24096111
Citation
Gadducci A, Sartori E, Maggino T, Zola P, Cosio S, Zizioli V, Lapresa M, Piovano E, Landoni F. Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study). Gynecol Oncol. 2013 Dec;131(3):640-4. doi: 10.1016/j.ygyno.2013.09.029. Epub 2013 Oct 3.
Results Reference
background
PubMed Identifier
19181826
Citation
Lissoni AA, Colombo N, Pellegrino A, Parma G, Zola P, Katsaros D, Chiari S, Buda A, Landoni F, Peiretti M, Dell'anna T, Fruscio R, Signorelli M, Grassi R, Floriani I, Fossati R, Torri V, Rulli E. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009 Apr;20(4):660-5. doi: 10.1093/annonc/mdn690. Epub 2009 Jan 30.
Results Reference
background
PubMed Identifier
15961761
Citation
Buda A, Fossati R, Colombo N, Fei F, Floriani I, Gueli Alletti D, Katsaros D, Landoni F, Lissoni A, Malzoni C, Sartori E, Scollo P, Torri V, Zola P, Mangioni C. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005 Jun 20;23(18):4137-45. doi: 10.1200/JCO.2005.04.172.
Results Reference
background
PubMed Identifier
24342439
Citation
Landoni F, Sartori E, Maggino T, Zola P, Zanagnolo V, Cosio S, Ferrari F, Piovano E, Gadducci A. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study. Gynecol Oncol. 2014 Mar;132(3):611-7. doi: 10.1016/j.ygyno.2013.12.010. Epub 2013 Dec 14.
Results Reference
background
Learn more about this trial
NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB
We'll reach out to this number within 24 hrs